Free preview

Acute Lymphoblastic Leukemia/Lymphoma (ALL)

Overview and clinical definition are open. Full Step 1 details unlock with a plan.

For the why behind the fact

Use this page to connect what you are memorizing.

Start with the overview when a class slide, Anki card, or qbank explanation feels too thin. Then use presentation and workup to recognize the condition, and differentials to separate look-alikes.

Overview


Plain-Language Overview

Acute lymphoblastic leukemia/lymphoma is cancer of immature immune cells called lymphoblasts. When these cells build up in bone marrow, they can reduce normal blood-cell production, causing fatigue, infections, bruising and bleeding. The related lymphoblastic lymphoma presentation mainly forms masses in lymph nodes or other tissues. Both can spread and require prompt specialist treatment. ALL is especially common in young children but can occur at any age.

Clinical Definition

B- or T-lymphoblastic leukemia/lymphoma is a clonal malignancy of lymphoid precursors with impaired maturation. ALL denotes the predominantly marrow/blood presentation; lymphoblastic lymphoma denotes predominantly tissue disease on the same biological spectrum. Marrow involvement causes anemia, thrombocytopenia and impaired normal leukocyte production; nodes, liver, spleen, CNS and testes may be involved. Examples of B-ALL alterations are t(12;21), ETV6::RUNX1, and t(9;22), BCR::ABL1. Morphology, a flow-cytometry panel and genetic testing establish the subtype. Treatment and prognosis depend on age, biology and response, including measurable residual disease.

Clinical Presentation


Diagnostic Workup


Pathophysiology


Treatments


Prevention


Outcome & Complications


Differential Diagnoses